baber/WOPTO huggingface dataset:
Patent EP-3333599-A2 (EP)
Inventor: HEGENBARTH ROBIN
IPC: G02B23/24
Filed: 2017-11-15
Abstract: A negative lens, in particular a negative lens (1, 11) for an oblique-view endoscope objective (20), has a first face with a first optical surface and a second face with a second optical surface opposing the first optical surface, the second optical surface being a concave optical surface (3, 13), wherein a recess (7, 17) is formed in the second face adjacent to the concave optical surface (3, 13). The invention also relates to an endoscope objective, in particular to an oblique-view endoscope objective (20), that comprises a deflection prism (22) having an entrance face and further comprising a negative lens (1, 11, 51), the negative lens (1, 11, 51) having a first face with a first optical surface and a second face with a second optical surface opposing the first optical surface, the second optical surface being a concave optical surface (3, 13, 53). The negative lens (1, 11, 51) is mounted on a distal planar surface of the deflection prism (22) such that a rim (4, 14, 54) encompassing the concave optical surface (3, 13, 53) abuts the distal planar surface of the deflection prism (22).
Patent EP-3251677-A2 (EP)
Inventor: SAHA UTTAM
IPC: A61P3/12
Filed: 2010-01-26
Abstract: This invention relates to methods and small molecules having a phosphate group that can be used to inhibit phosphate transport and to treat or prevent diseases that are related to disorders in the maintenance of normal serum phosphate levels.
Patent EP-3519295-A2 (EP)
Title: An oblique rotor-wing aircraft
Inventor: COMBS CORY MICHAEL
IPC: B64C27/30
Filed: 2017-09-29
Abstract: An oblique rotor-wing aircraft may be capable of vertical take-off and landing, subsonic cruise, transonic cruise, and/or supersonic cruise. The oblique rotor-wing aircraft may comprise one or more of a fuselage, a rotor-wing, a thrust-vectored propulsion system, a locking mechanism, and/or other components. The rotor-wing may be rotatably coupled to the fuselage. The rotor-wing may rotate about an axis in a first flight mode for vertical takeoff and landing. The oblique rotor-wing aircraft may include a thrust-vectored propulsion system that drives the rotation of the rotor-wing about the axis. The thrust-vectored propulsion system may include multiple, separately operable propulsion systems coupled to the rotor-wing and/or the fuselage. The oblique rotor-wing aircraft may comprise a locking mechanism that locks the rotor-wing at an angle oblique to the fuselage responsive to initiation of a second flight mode. The rotor-wing may be fixed at an angle oblique to the fuselage during the second flight mode.
Patent EP-3471099-A2 (EP)
Inventor: DU YANBIN
IPC: G10L25/51
Filed: 2018-10-15
Abstract: A speech processing method and a terminal are provided. The method includes: receiving signals from a plurality of microphones; performing, by using a same sampling rate, analog-to-digital conversion on the plurality of paths of signals received from the plurality of microphones, to obtain a plurality of paths of time-domain digital signals; performing time-to-frequency-domain conversion on the plurality of paths of time-domain digital signals to obtain a plurality of paths of frequency-domain signals; and determining a signal type of the primary frequency-domain signal based on at least one of a sound pressure difference between the primary frequency-domain signal and each of N paths of secondary frequency-domain signals in the M paths of secondary frequency-domain signals, a phase difference between the primary frequency-domain signal and each of the N paths of secondary frequency-domain signals, and a frequency distribution characteristic of the primary frequency-domain signal.
Patent EP-3621599-A2 (EP)
Inventor: URAZ EZEL
IPC: A61K9/16
Filed: 2018-05-10
Abstract: The present invention relates to solid oral pharmaceutical compositions, comprising dabigatran etexilate in the form of the free base or in the form of pharmaceutically acceptable salts, polymorphs, solvates, hydrates or esters thereof.
Patent EP-3638256-A2 (EP)
Title: Antimicrobial compounds and nanostructures
Inventor: MONTEIRO MICHAEL
IPC: C08F120/34
Filed: 2018-06-13
Abstract: The present disclosure provides compounds and nanostructures having one or more quaternary ammonium salts, compositions including the compounds and nanostructures, and methods useful for treating conditions using the compounds, nanostructures, and compositions. In at least one aspect, a compound is represented by formula (I): or a pharmaceutically acceptable salt thereof, wherein: Q is fluoro, chloro, bromo, or iodo; each of s, b, and n is independently an integer from about 10 to about 100; and each of v, j, p, z, q, x and m is independently an integer from 1 to about 20.
Patent EP-3648210-A2 (EP)
Inventor: CHAE JONGHYUN
IPC: H01M4/62
Filed: 2018-09-21
Abstract: The present invention relates to a particle with a yolk-shell structure including a carbon shell; and a silicon (Si) core provided inside the carbon shell, wherein at least a part of the shell is spaced apart from the core, and the particle with a yolk-shell structure has a micropore volume of 0.15 cm 3 /g or less, and a method for preparing the same.
Patent EP-3545864-A2 (EP)
Inventor: SHELTON FREDERICK E IV
IPC: A61B90/00
Filed: 2019-03-28
Abstract: A surgical instrument system comprising an adaptive control system is disclosed.
Patent EP-3581846-A2 (EP)
Inventor: SHIKATA SATOSHI
IPC: F21S41/275
Filed: 2019-05-20
Abstract: A vehicular lamp is capable of projecting light in a forward direction and light in a direction different of the projection lens from the forward direction. The vehicular lamp includes: a light source (3) that emits light forward, and a projection lens (4) that projects light emitted from the light source (3) forward. The projection lens (4) includes a first lens surface (4a) located on a side facing the light source (3), and receiving light emitted from the light source (3), a second lens surface (4b) located on a side opposite to the first lens surface (4a) to output received light forward, and an output portion (14) located on an outer peripheral side surface between the first lens surface (4a) and the second lens surface (4b) and configured to output a part of light (L') having been incident on and entered through the first lens surface (4a) in a direction different from the forward direction.
Patent EP-3749723-A2 (EP)
Inventor: XIE HAN
IPC: C08F220/06
Filed: 2019-02-08
Abstract: The present disclosure is directed to a UV-curable non-isocyanate polyuria polymer and a UV-curable coating composition containing the same. The UV-curable non-isocyanate polyurea polymer has one or more ethylenically unsaturated functional groups and the ethylenically unsaturated functional groups are attached to nitrogen atoms present in a backbone urea segment via -C(=O)- linkage. The non-isocyanate polyurea polymer is prepared by: (i) providing an ethylenically unsaturated compound having one or more carboxylic acid functional groups; and (ii) reacting said ethylenically unsaturated compound having one or more carboxylic acid functional groups with a multi-carbodiimide polymer to form the non-isocyanate polyurea polymer.
Patent EP-3853328-A2 (EP)
Inventor: PFISTER PATRICK
IPC: C11B9/00
Filed: 2019-12-17
Abstract: The various aspects presented herein relate to the perfumery industry. More particularly, the various aspects presented herein relate to compositions and/or ingredients that increase a subject's perception of floral muguet compounds, methods for intensifying a subject's perception of floral muguet compounds, as well as to the perfumed articles or perfuming compositions comprising as an active ingredient, at least one compound selected from octanal; (E)-dec-2-enal, 2-phenylpropanal; (E)-but-2-enal; 3-methylbenzaldehyde; 3-(1,3- benzodioxol-5-yl)-2-methylpropanal; (+-)-3-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-carbaldehyde, (+-)-4-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-carbaldehyde, and mixtures thereof; heptanal, 4-Propan-2-ylbenzaldehyde; (3R)-3,7-dimethyloct-6-enal; (+)-(3S)-3- [(1R)-4-methyl-3-cyclohexen-1-yl]butanal, (+)-(3R)-3-[(1R)-4-methyl-3-cyclohexen-1- yl]butanal, and mixtures thereof; hexanal; 2,6-dimethylhept-5-enal; benzaldehyde; 2-methyl- 3-(4-methylphenyl)propanal; 3,5,6-trimethyl-3-cyclohexene-1-carbaldehyde, 2,4,6-trimethyl- 3-cyclohexene-1-carbaldehyde, and mixtures thereof; 4-ethylbenzaldehyde; 6-methoxy-2,6- dimethylheptanal; (E)-non-2-enal; and combinations thereof.
Patent EP-3880326-A2 (EP)
Inventor: DEAN JONATHAN
IPC: G06F3/01
Filed: 2019-10-28
Abstract: A technology is described for generating sensory effects linked to virtual objects. In one example, a virtual object associated with a sensory attribute can be generated in a virtual reality environment. The virtual object may be associated with a sensory attribute which can be simulated using a defined sensory input generated by a sensory rendering device. A virtual object position can be determined for the virtual object relative to a virtual user position for a virtual user in the virtual reality environment. One or more sensory rendering devices can be identified to generate the defined sensory input, and the one or more sensory rendering devices can be activated to generate the defined sensory input.
Patent EP-4085021-A2 (EP)
Inventor: ALGÜL YUSUF CAN
IPC: B08B9/02
Filed: 2019-12-31
Abstract: La présente invention concerne un appareil de nettoyage de tuyauterie de boisson qui permet un processus de nettoyage facile et traçable. L'appareil et le système selon l'invention peuvent optimiser le processus de nettoyage par surveillance et utilisation dynamiques de connexions à distance afin d'effectuer un processus de nettoyage efficace.
Patent EP-3736902-A2 (EP)
IPC: H01M10/42
Filed: 2020-07-15
Abstract: Leak testing system (100) and method for leak testing a finished battery cell, comprising a vacuum chamber (4), a vacuum pump (6), a detecting and measuring system (1) to detect gases and/or vapors escaping from the cell, the gases and/or vapors deriving from parts and/or substances inside in the cell, and a capillary element (2) which connects the detecting and measuring system to the vacuum chamber and through which the gases and/or vapors leaking from the cell flow. The system further comprises heating devices adapted to heat at least one of the components of system, thereby making the system substantially memory-free.
Patent EP-4017879-A2 (EP)
Inventor: THROSBY MARK
IPC: A61P35/00
Filed: 2020-08-19
Abstract: Cette invention concerne des anticorps ou des parties fonctionnelles, des dérivés et/ou analogues de ceux-ci qui comprennent un domaine variable qui se lie à une partie extracellulaire de EGFR et un domaine variable qui se lie à une partie extracellulaire de LGR5, pour une utilisation dans le traitement du cancer, l'anticorps ou la partie fonctionnelle, le dérivé et/ou analogues de celui-ci étant administré avec un inhibiteur de la topoisomérase de type I.
Patent EP-3976009-A2 (EP)
Title: Inhibiteurs de bax et leurs utilisations
Inventor: MATSUYAMA SHIGEMI
IPC: A61P35/00
Filed: 2020-06-01
Abstract: L'invention concerne un composé de formule (I) ou (II) destiné à être utilisé pour inhiber la mort cellulaire médiée par Bax et/ou l'apoptose.
Patent EP-4103214-A2 (EP)
Inventor: LOMBARDI LAURA
IPC: A61K48/00
Filed: 2021-02-11
Abstract: The present disclosure provides methods and compositions useful for the treatment or prevention of heart disease. In particular, the present disclosure provides a vector comprising a modified troponin T promoter operatively linked to a therapeutic gene product for the treatment or prevention of heart disease,  e.g. , cardiomyopathy. The disclosure also provides recombinant adeno-associated virus (rAAV) virions, rAAV viral genomes, and expression cassettes and pharmaceutical compositions thereof. The disclosure further provides methods for treating a disease or disorder, such as heart disease.
Patent EP-4142788-A2 (EP)
Inventor: PHAM RANDAL TANH HOANG
IPC: A61K41/00
Filed: 2021-05-03
Abstract: A composition for treating abnormal or excessive angiogenesis, such as pyogenic granuloma comprising an anti-vascular endothelial growth factor (anti-VEGF) agent ( e.g. , an antibody or small molecule inhibitor of VEGF signaling) and a carrier comprising nanoparticles. Methods of treating abnormal or excessive angiogenesis by administering a composition comprising an anti-VEGF agent and nanoparticles, alone or in combination with administering an anti-inflammatory steroid, and administering a non-steroidal anti-inflammatory drug (NSAID) to a subject. Devices for administering the composition for treating pyogenic granuloma are also disclosed.
Patent EP-4240853-A2 (EP)
Inventor: GIMENEZ CARLA ALEJANDRA
IPC: C12N15/113
Filed: 2021-11-03
Abstract: Provided herein are novel Class 2 Type II, Type V, type VI CRISPR-Cas RNA-guided endonucleases and systems comprising the same. Provided also are methods of making, and methods of use thereof. Exemplary methods of use include modifying target nucleic acids useful for therapeutic applications, and also include detecting targeting nucleic acids, useful for diagnostic applications.
Patent EP-4251139-A2 (EP)
Title: Compositions and methods for treating migraine
Inventor: CARCILLO DENIEL
IPC: A61K31/00
Filed: 2021-11-30
Abstract: As described below, the present disclosure features compositions containing a cannabidiol (CBD) and/or psilocybin, optionally in combination with a mushroom blend. The present disclosure also features methods for treating or preventing migraine, or symptoms thereof, with a cannabidiol and/or psilocybin, optionally in combination with a mushroom blend. The present disclosure also features compositions and methods of using psilocybin in combination with a neurotransmitter activity modulator for the treatment of neurological conditions (e.g., migraine), or symptoms thereof (e.g., anxiety or depression).
Patent EP-4059456-A2 (EP)
Inventor: FALLER CRAIG N
IPC: A61B17/32
Filed: 2014-12-08
Abstract: A surgical apparatus includes an end effector having an ultrasonic blade, a clamp arm, and a clamp pad. The end effector applies ultrasonic energy at the blade. The clamp arm pivots relative to the blade. The clamp pad is positioned on the clamp arm adjacent to the blade. The clamp arm includes a latching feature to retain the clamp pad relative to the clamp arm to prevent the clamp pad from moving laterally, longitudinally, and perpendicularly relative to the clamp arm.
Patent EP-4050014-A2 (EP)
Title: Organometallic solution based high resolution patterning compositions
Inventor: MEYERS STEPHEN T
IPC: G03F7/004
Filed: 2015-10-22
Abstract: Organometallic radiation resist compositions are described based on tin ions with alkyl ligands. Some of the compositions have branched alkyl ligands to provide for improved patterning contrast while maintaining a high degree of solution stability. Blends of compounds with distinct alkyl ligands can provide further improvement in the patterning. High resolution patterning with a half-pitch of no more than 25 nm can be achieved with a line width roughness of no more than about 4.5 nm. Synthesis techniques have been developed that allow for the formation of alkyl tin oxide hydroxide compositions with very low metal contamination.
Patent EP-4218753-A2 (EP)
Inventor: ANANDAN SAMPATH-KUMAR
IPC: A61K31/365
Filed: 2018-07-12
Abstract: Provided herein are novel lipase inhibitors and methods for using the same to treat inflammation, multisystem organ failure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis (e.g., culture negative sepsis), burns, and acne. For example, provided herein are two novel lipase inhibitors useful in the methods described herein:or a pharmaceutically acceptable salt thereof.
Patent EP-4198828-A2 (EP)
Inventor: KIM JUN-SUNG
IPC: G06N3/065
Filed: 2022-11-17
Abstract: A neuromorphic system according to an embodiment of the invention includes an input signal section that generates an input signal, a synapse section that includes a plurality of synaptic units that receive the input signal and makes a current to flow according to a set weight, each of the plurality of synaptic units including a plurality of non-volatile memory cells capable of selectively storing a logical state, the non-volatile memory cells being arranged in a memory array that include input electrode lines and output electrode lines crossing each other, and generates an output signal for each output electrode line by the input signal, a digital calculation section that digitizes the output signal generated for each output electrode line and calculates a sum of the digitized output signals, and a controller section that controls the input signal section, the synapse section, and the digital calculation section, and the controller section designates the number of digitized digits for each output electrode line and stores the logic state in the plurality of non-volatile memory cells according to a predetermined weight in each of the plurality of synaptic units, causes the input signal generated by the input signal section to be applied to each of a plurality of non-volatile memory cells of each of the plurality of synaptic units through the input electrode lines, generates, as the output signal, a sum of currents flowing from the plurality of non-volatile memory cells of each of the plurality of synaptic units by the applied input signal for each output electrode line, and causes the digital calculation section to digitize the output signal generated for each output electrode line according to the number of digits and calculate the sum of the digitized output signals.
Patent EP-4193971-A2 (EP)
Title: Verfahren zur herstellung einer orthese sowie orthese
Inventor: HOFFMANN MARCO
IPC: A61F5/01
Filed: 2022-12-12
Abstract: Die Erfindung betrifft ein Verfahren zur Herstellung einer Orthese mit folgenden Schritten:a) Erstellen eines digitalen Abbildes (1) eines zu versorgenden Körperteils,b) Erstellen einer digitalen Zweckform (2) des zu versorgenden Körperteils anhand des digitalen Abbildes,c) Markieren wenigstens eines digitalen Polsterbereichs (3) der digitalen Zweckform (2),d) Erstellen einer digitalen Orthese (4) und wenigstens eines digitalen Polsterträgers (5) anhand der digitalen Zweckform (2) und des wenigstens einen digitalen Polsterbereichs (5),e) Erstellen einer realen Orthese (6) und wenigstens eines realen Polsterträgers (7) anhand der digitalen Orthese (4) und des digitalen Polsterträgers (5) undf) Fügen des wenigstens einen realen Polsterträgers (7) mit der realen Orthese (6).
Patent EP-4210233-A2 (EP)
Title: Tactical/legacy waveform obfuscation through independent spreading overlay
Inventor: YASKOFF NICHOLAS T
IPC: H04B1/707
Filed: 2023-01-11
Abstract: Communicating using spread spectrum. A legacy RF signal is intercepted from a legacy radio, spread spectrum processing is performed on the legacy RF signal to create a spread signal. The spread signal is transmitted to a receiver, whereafter the spread signal is de-spread to recover the legacy RF signal.
Patent EP-4219355-A2 (EP)
Inventor: GEHIN ANTHONY
IPC: B65G47/51
Filed: 2016-06-24
Abstract: L'invention a pour objet un dispositif d'alimentation (1) d'au moins une surface de réception entre deux postes successifs dans une ligne industrielle de traitement de produits (3) à la chaîne, présentant une zone de prise (4) d'où les produits (3) sont transférés vers ladite surface, et comportant un convoyeur d'entrée (5) pour recevoir et maintenir un flux compact de produits (3) reçu du poste en amont, un convoyeur de réception (6), s'étendant le long d'une direction de convoyage (7) en zone de prise (4) pour y recevoir puis y arrêter le flux de produits (3) fournis par le convoyeur d'entrée (5), ainsi qu'un moyen de transfert (8), pour déplacer, transversalement à la direction de convoyage (7), vers la surface de réception, les produits (3) à l'arrêt en zone de prise (4).Ce dispositif est caractérisé en ce qu'il comprend, en outre, au moins un moyen de convoyage tampon, apte à, d'une part, recevoir le flux compact de produits (3) depuis le convoyeur d'entrée (5) lorsque les produits (3) sont à l'arrêt sur le convoyeur de réception (6) pour leur transfert, et, d'autre part, conserver la compacité dudit fluxL'invention a aussi pour objet un dispositif de préparation et un procédé correspondant.
Patent EP-4218914-A2 (EP)
Inventor: WU KENNETH
IPC: A61N1/20
Filed: 2019-02-20
Abstract: Disclosed herein are systems and methods for nerve conduction block that can involve the delivery of relatively high amounts of charge safely to tissue. Such systems and methods can include control systems for safely monitoring a direct current electrode system, including delivering direct current via an electrode lead to a target tissue of a patient; measuring the driving voltage across the electrode; comparing the driving voltage across the electrode to predetermined threshold range values; measuring the body impedance; determining a voltage drop across the lead from the body impedance measurement; and adjusting the driving voltage to maintain the voltage drop across the lead within a predetermined voltage range.
Patent EP-4257212-A2 (EP)
Title: Ferseneinheit für eine gleitbrettbindung mit mz-auslösung über nockenkörper
Inventor: ECKART UWE
IPC: A63C9/08
Filed: 2023-03-14
Abstract: Die vorliegende Erfindung betrifft eine Ferseneinheit (10; 110) für eine Gleitbrettbindung, insbesondere für eine Tourenbindung, umfassend eine Basis (12; 112) mit einer Befestigungsanordnung (14; 114) zur Befestigung an einem Gleitbrett, einen Bindungskörper (16; 116), welcher relativ zur Basis (12; 112) um eine orthogonal zu einer Gleitbrettebene (E) verlaufende Auslösedrehachse (A) drehbar ist, am Bindungskörper (16; 116) angeordnete Kopplungsmittel (18; 118), welche dafür eingerichtet sind, in einer Abfahrtsstellung der Gleitbrettbindung in Eingriff mit einem Fersenabschnitt eines Gleitbrettschuhs zu stehen, um den Gleitbrettschuh an der Gleitbrettbindung festzuhalten, wobei die Kopplungsmittel (18; 118) in der Abfahrtsstellung in einer Gleitbrettlängsrichtung (x), insbesondere in einer Fahrtrichtung nach vorne, von dem Bindungskörper (16; 116) vorstehen, und einen Mz-Auslösemechanismus (26, 28, 30, 38, 40, 50; 126, 128, 130, 138, 140), welcher dazu eingerichtet ist, die Kopplungsmittel (18; 118) derart in die Abfahrtsstellung vorzuspannen, dass sie sich in der Abfahrtsstellung bei Einwirkung einer eine vorbestimmte Auslösekraft überschreitenden Kraft aus dem Eingriff mit dem Gleitbrettschuh lösen und sich durch eine Drehbewegung des Bindungskörpers (16; 116) um die Auslösedrehachse (A) aus der Abfahrtsstellung in eine Auslösestellung bewegen, wobei der Mz-Auslösemechanismus eine Federanordnung (30, 38, 50; 130, 138) mit einem Federmittel (30; 130) aufweist, welches die vorbestimmte Auslösekraft bestimmt, und wobei der Mz-Auslösemechanismus (26, 28, 30, 38, 40, 50; 126, 128, 130, 138, 140) einen am Bindungskörper (16; 116) angeordneten Nockenkörper (40; 140) umfasst, welcher dazu eingerichtet ist, in der Abfahrtsstellung mit einer Gegenkontur (28; 128) einer an der Basis (12; 112) vorgesehenen Nockenfläche (26; 126) in Kulisseneingriff zu treten, wobei die Federanordnung (30, 38, 50; 130, 138) dazu eingerichtet ist, eine Zugkraft auf den Nockenkörper (40; 140) auszuüben, um ihn in Kulisseneingriff mit der Gegenkontur (28; 128) der Nockenfläche (26; 126) zu ziehen.